评价体现:从痴呆症患者的舞蹈实践中获得的见解
1Global Brain Health Institute, San Francisco, CA, United States.
Frontiers in neurology
|June 21, 2023
概括
以人为中心的舞蹈干预可以改善痴呆症患者的大脑健康,增强认知能力,流动性和情感福祉. 需要进一步的研究来了解共同创作舞蹈的好处和促进合作.
科学领域:
- 老年学是指老年学的学科.
- 神经科学是一个神经科学.
- 艺术与健康 艺术与健康
背景情况:
- 基于艺术的方法,特别是舞蹈,有望改善痴呆症患者的大脑健康.
- 舞蹈对认知,移动性和情感/社会福祉有积极的影响.
- 现有的研究存在差距,特别是关于共同创作和即兴舞蹈实践.
研究的目的:
- 讨论当前的挑战和知识差距,以了解舞蹈对痴呆症患者的价值.
- 倡导跨学科的合作,以促进舞蹈实践的理解和实施.
主要方法:
- 审查当前的文献和舞蹈和痴呆症的实践.
- 讨论作者作为社区舞蹈艺术家和倡导者的经验.
- 强调需要合作研究模式.
主要成果:
- 基于艺术,以人为中心的方法为痴呆症中的大脑健康提供了多方面的好处.
- 共创和即兴舞蹈实践需要进一步调查.
- 跨学科的合作对于推进研究和实践至关重要.
结论:
- 舞蹈干预具有改善痴呆症患者生活质量的巨大潜力.
- 涉及神经科学家,舞蹈艺术家和痴呆症患者的合作研究至关重要.
- 未来的研究应该专注于共同创作舞蹈,以充分理解其价值并优化其应用.
相关概念视频
Dementia
143
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
143
Social Facilitation
32.0K
Not all intergroup interactions lead to negative outcomes. Sometimes, being in a group situation can improve performance. Social facilitation occurs when an individual performs better when an audience is watching than when the individual performs the behavior alone. This typically occurs when people are performing a task for which they are skilled.
32.0K
Alzheimer's Disease: Overview
532
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
532
Intellectual Disability
120
Intellectual disability (ID) is a neurodevelopmental condition characterized by deficits in intellectual and adaptive functioning that manifest during the developmental period. This condition encompasses challenges in reasoning, memory, problem-solving, and learning, accompanied by impairments in everyday life skills, such as communication, self-care, and social interactions. Intellectual disability affects approximately 1% of the population in the United States, impacting an estimated 5...
120
Parkinson's Disease: Overview
611
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
611
Alzheimer's Disease: Treatment
223
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
223


